About this episode
El director de análisis de Bankinter, Ramón Forcada, analiza la caída de Novartis y nos deja una previa de los resultados de Inditex.
Get every episode summarized
Each time Capital, la Bolsa y la Vida publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Capital, la Bolsa y la Vida
Roberto Moro analiza los títulos de Merlin Properties
Capital, la Bolsa y la Vida
Sep 9, 20261:18pending
Consultorio de Bolsa con Roberto Moro
Capital, la Bolsa y la Vida
Sep 9, 202621:27pending
El Minuto de Oro de Roberto Moro
Capital, la Bolsa y la Vida
Sep 9, 20261:59pending
La Fed subirá tipos la próxima semana para "no dar muestras de debilidad"
Capital, la Bolsa y la Vida
Sep 9, 20267:02pending